HOME >> MEDICINE >> NEWS
Balancing care decisions for gravely ill patients

ROCHESTER, Minn. -- Mayo Clinic researchers studying gravely ill intensive care unit (ICU) patients found that unrealistic family expectations resulted in the increased use of health care resources without a significant improvement in survival rate among these patients.

The February Mayo Clinic Proceedings study is important for patients who have a high likelihood of death in a hospital. Early, accurate identification of these patients when they arrive at the hospital might limit potentially futile, aggressive ICU care to such patients. However, limiting such aggressive care based on inaccurate tools might shorten potentially productive lives, says Keith Berge, M.D., a Mayo Clinic anesthesiologist who was the lead researcher.

In this study, researchers used the Acute Physiology and Chronic Health Evaluation III (APACHE III), a computerized system that is designed to prospectively predict mortality rates in "real time" for ICU patients, to identify a group of patients with a very low predicted likelihood of survival. This group of extremely ill patients was then looked at in more detail.

The researchers compared a group of these patients in which the families had unrealistic expectations of survival with a group of patients whose families' expectations were deemed appropriate. They found that patients whose families had unrealistic expectations used substantially more ICU resources. The median number of days in ICU for all patients was four, while the median number of days in ICU for patients whose families had unrealistic expectations was 11 days. While these patients survived to hospital discharge at a higher rate than others (33 percent versus 17 percent), their survival one year later did not differ much from those without documentation of unrealistic expectations (11 percent versus 6 percent). Nearly all survivors were severely disabled at discharge and at one year.

"Perhaps the best way to avoid vast expenditures of resources on
'"/>


1-Feb-2005


Page: 1 2 3

Related medicine news :

1. Accountability in Clinical Research: Balancing Risk and Benefit
2. How the stories of ordinary people could give them more say over planning decisions
3. Web-based tool to help clinicians make schizophrenia treatment decisions
4. Fair decisions more important when hospitals face crisis like SARS
5. Concerns about fertility affect treatment decisions in one-third of young breast cancer patients
6. European study highlights frequency of medical end-of-life decisions in terminally ill pts
7. Brain imaging study reveals interplay of thought and emotion in economic decisions
8. Peer pressure matters in young adults smoking decisions
9. Computerized tool predicts sarcoma outcome and improves ability to make better treatment decisions
10. Hormonal treatment improves survival in high-risk prostate cancer patients
11. Study finds that coordinating care of chronically ill patients does not increase liability

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/24/2016)... ... 2016 , ... NutraPre today announced the nationwide release of ... prevent morning sickness and promote overall heath. Engineered with advanced nanotechnology, this beverage ... water. , “Imagine a pregnancy without morning sickness,” NutraPre CEO Eddie Cameron said. ...
(Date:5/23/2016)... ... 2016 , ... On the occasion of his 25th Anniversary of changing and ... process: , New patients have a consultation and evaluation (done by Dr. Ferdico personally). ... Body Composition Analysis, There are 15 things that each patient gets checked for, ...
(Date:5/23/2016)... ... May 23, 2016 , ... According to an article published May 12th on the ... oral health and hygiene. The article points out that, as long as patients are brushing ... become worn and frayed. Of course, these worn-out bristles won’t clean teeth and gum tissue ...
(Date:5/23/2016)... ... May 23, 2016 , ... According to an ... an exuberant mood since the birth of her son, Rockwell Lloyd Liu, and notes ... had.” The “Elementary” and “Kill Bill” star explains that, as a career oriented single ...
(Date:5/23/2016)... ... May 23, 2016 , ... ... of high-level representatives from the Japan PMDA, US FDA, industry and academia at ... CDISC standards help format data from clinical trials so that it can be ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... 2016   Purdue Pharma L.P.  today announced ... with Egalet Corporation and Acura Pharmaceuticals, Inc. that ... the agreement the companies will exchange valuable patent ... companies to develop and sell several opioid pain ... reflects the commitment of Purdue Pharma to seek ...
(Date:5/20/2016)... May 20, 2016 - ... Technologies, Insulins, Growth Hormones, Recombinant Coagulation Factors and ... - This New Study Reveals Selling Opportunities and ... ,What is the future of biologics, ... technological and commercial analysis. Staying ahead in data ...
(Date:5/19/2016)... Cellvizio Highlighted in Physician Presentations and ... 91 st Congress of the Japan Gastroenterological ... MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary ... Cellvizio platform is being highlighted at two major ... of May. The first meeting highlighting Cellvizio is ...
Breaking Medicine Technology:
Cached News: